Carlyle is wrapping up a two-year fundraising campaign for its eighth secondaries flagship, CEO Harvey Schwartz said on the ...

In the midst of all the cloak and dagger secrecy surrounding the potential sale of the Boston Celtics, lost in the shuffle of ...

The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...

U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...

Medicare insurer SelectQuote has received a $350m investment from funds managed by Bain Capital, Morgan Stanley Private ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Apleona is a European provider of integrated facility management. Bain Capital has acquired Apleona from PAI Partners.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...